Past Workshops and Publications 2007-2005

Benefit-Risk

2013-2012 |2011-2010 | 2009-2008 | 2007-2005 | 2004-2002

YEAR DESCRIPTION DOWNLOADS AND PUBLICATIONS
2007 The Emerging Markets: Models of Best Practice for the Regulatory Review of New Medicines, Geneva, Switzerland: 5-6 December 2007 Workshop Report PDF
  New approaches to product approval: Balancing early release with improved safety monitoring, 14-15 June 2007, Washington DC, USA

Workshop Report PDF

  Rethinking early clinical testing: The translation from laboratory to clinic, Cobham, Surrey, UK: 16-17 April 2007

Workshop Report PDF

2006 Quality Decision-Making: Procedures and practices in drug development and the regulatory review, Cobham, Surrey, UK: 7-8 December 2006 Workshop Report PDF
  Global Drug Development: Asia's role and contribution, Tokyo, Japan: October 2006

Workshop Report PDF

  New Technologies and Biomarkers: The Way Ahead, Washington, D.C., USA: May 2006

Workshop Report PDF

  Emerging Markets: Assessing the regulatory environment and its impact on patients’ access to new medicines  Geneva Switzerland: 2-3 March 2006  (Postponed from December 2005) Workshop Report PDF
2005 A new paradigm for clinical research: A discussion of the ways pharmaceutical R&D needs to change in order to remain viable, Washington D.C:  3-4 October 2005

Workshop Report PDF

 

Benefit-risk assessment model for medicines: Developing a structured approach to decision making, Washington DC, USA: 13-14 June 2005

Workshop Report PDF

  Post-approval commitments and conditional authorisations, Cobham, Surrey, UK: 13-14 May 2005 

Workshop Report PDF

2012-2010 | 2009-2008 | 2007-2005 | 2004-2002